Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc (GBP) | WHCGRegistrer dig for at låse op for ratings |
Fondens performance | 30-04-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | - | - | - | - | 7,2 | |
+/-Kat | - | - | - | - | 3,7 | |
+/-Indeks | - | - | - | - | 0,8 | |
Kategori: Sektor - Sundhed, Aktier | ||||||
Kategoribenchmark: Morningstar Gbl Health TME ... |
Oversigt | ||
Closing Price 15-05-2024 | GBX 477,03 | |
Kursændring 1 dag | 1,14% | |
Morningstar Kategori™ | Sektor - Sundhed, Aktier | |
Omsætning | 0 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | IE000L4EH2K5 | |
Markedsværdi i alt (mio.) 14-05-2024 | USD 2,39 | |
Seneste TNA(mio.) 14-05-2024 | USD 2,39 | |
Løbende omkostning 26-03-2024 | 0,18% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc (GBP) | WHCG |
The investment objective of the Fund is to achieve the net total return of the S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care Index (the "Reference Index") less fees, expenses and transaction costs. |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
- - | ||
Startdato 12-04-2023 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
S&P Dev x-Kor LMCap ESG Enh HC NR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Formuefordeling Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc (GBP) | WHCG | 19-01-2024 |
|
|
Top 5 placeringer | Sektor | % |
UnitedHealth Group Inc | Healthcare | 10,12 |
Eli Lilly and Co | Healthcare | 7,45 |
AbbVie Inc | Healthcare | 6,93 |
Novo Nordisk A/S Class B | Healthcare | 5,02 |
Merck & Co Inc | Healthcare | 4,48 |
Øget Mindsket Ny siden sidste portefølje | ||
Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc (GBP) | WHCG |